The Hong Kong HIV Cohort Database is an observational cohort including all patients enrolled in 2 HIV specialist clinical services in Hong Kong. Basic demographics, HIV transmission category, and the diagnoses of AIDS were captured using a standardized template. As of December 2006, 2132 HIV cases had been registered in the database, representing two thirds of all reports submitted to the government’s surveillance system. Non-Chinese and young females ≤24 years were less represented in the cohort. Description of cohort cases was, however, more complete in terms of transmission category and presentation with AIDS-defining illnesses. Overall, Pneumocystis jirovecci, tuberculosis, and systemic mycosis accounted for a majority of AIDS cases within 3 months of HIV diagnosis. There was a gradual rise of HIV positive men having sex with men in the cohort, notably after 2002, an observation also made in other Asian countries.
Fauci A.25 years of HIV. Nature. 2008;453:289-290.
2.
Lau B., Gange SJ, Moore RDInterval and clinical cohort studies: epidemiological issues. AIDS Res Hum Retroviruses. 2007;23:769-776.
3.
Vlahov D., Anthony JC, Muñoz A., et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues . 1991;21:759-776.
4.
van Ameijden EJ, van den Hoek JA, Coutinho RALarge declines in sexual risk behavior with noncommercial partners among heterosexual injection drug users in Amsterdam, 1989-1995. Am J Epidemiol. 1996;144:772-781.
5.
Mallal SAThe Western Australian HIV Cohort Study, Perth, Australia. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 ;17(suppl 1):S23-S27.
6.
Moss AR, Bacchetti P., Osmond D., et al. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort . Br Med J (Clin Res Ed). 1988;296:745-750.
7.
Petoumenos K. ; The Australian HIV Observational Database. The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV observational database . J Clin Virol. 2003;26:209-222.
8.
Obel N., Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sørensen HTCohort profile: the Danish HIV Cohort Study [published online ahead of print September 17, 2008]. Int J Epidemiol . doi:10.1093/ije/dyn192.
9.
Egger M., Hirschel B., Francioli P., et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study . BMJ. 1997;315:1194-1199.
10.
The UK Collaborative HIV Cohort Steering Committee.The creation of a large UK-based multicentre cohort of HIV-infected individuals: the UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med. 2004;5:115-124.
11.
Perez-Hoyos S., Rodríguez-Arenas MA, García de la Hera M., et al. Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort. J Womens Health (Larchmt). 2007;16:1052-1061.
12.
Dieleman JP , Jambroes M., Gyssens IC, et al; ATHENA Study Group.Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort. AIDS. 2002;16:737-745.
13.
Phillips AN , Grabar S., Tassie JM, Costagliola D., Lundgren JD, Egger M.Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups . AIDS. 1999;13:2075-2082.
14.
Kingsley LA , Zhou SY, Bacellar H., et al. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol . 1991;134:331-339.
15.
Dunn D., Newell MLTransmission of HIV-1 from one child to another. European Collaborative Study . N Engl J Med.1994;330:1313-1314.
16.
The Antiretroviral Therapy (ART) Cohort Collaboration.HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006;368:451-458.
17.
Zhou J., Kumarasamy N., Ditangco R., et al; the TREAT Asia HIV Observational Database.The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr. 2005;38:174-179.
18.
Walker AS, Doerholt K., Sharland M., Gibb DM; Collaborative HIV Paediatric Study (CHIPS) Steering Committee.Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS. 2004;18:1915-1924.
19.
Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TDInfant feeding and risk of mother-to-child transmission of HIV-1 in São Paulo State, Brazil. São Paulo Collaborative Study for Vertical Transmission of HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol . 1998;19:189-194.
20.
Teerawattananon Y., Hanshaoworakul W., Russell S., Tangcharoensathien V., Jiamton S.Targeting antiretroviral therapy: lessons from a longitudinal study of morbidity and treatment in relation to CD4 count in Thailand. Asia Pac J Public Health. 2006;18:39-48.
21.
Cecelia AJ, Christybai P., Anand S., et al. Usefulness of an observational database to assess antiretroviral treatment trends in India. Natl Med J India. 2006;19:14-17.
22.
Karcher H., Omondi A., Odera J., Kunz A., Harms G.Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12:687-694.
23.
Nachega JB, Hislop M., Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43:78-84.
24.
Read JS, Cahn P., Losso M., et al; Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Obstet Gynecol . 2007;109:1358-1367.
25.
Corey DM, Kim HW, Salazar R., et al. Effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study. J Acquir Immune Defic Syndr. 2007;44:451-455.
26.
Lee SS, Lo YC, Wong KHThe first one hundred cases of AIDS in Hong Kong. Chin Med J (Engl). 1996;109:70-76.
27.
Choi T., Lee SSTracking HIV infection: Hong Kong. AIDS Reader. 2000;10:29-34.
28.
Centers for Disease Control and Prevention.1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults . MMWR Recomm Rep. 1992;41(RR-17):1-19.
29.
Wong KH, Lee SSComparing the first and second hundred AIDS cases in Hong Kong. Singapore Med J. 1998;39:236-240.
30.
Commission on AIDS in Asia.Redefining AIDS in Asia: Crafting an Effective Response. New Delhi, India: Oxford University Press; 2008.
31.
Lee SS, Tam DK, Ho RL, Wong KHShift of preference of location for sexual partnership in men having sex with men in an Asian population. Sex Health. 2008 ;5:373-374.
32.
Leung TW, Mak D., Wong KH, et al. Molecular epidemiology demonstrated three emerging clusters of human immunodeficiency virus type 1 subtype B infection in Hong Kong. AIDS Res Hum Retroviruses. 2008;24:903-910.
33.
Wong KH, Lee SS, Chan KCTwenty years of clinical human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in Hong Kong. Hong Kong Med J. 2006;12:133-140.
34.
Ruelle J., Roman F., Vandenbroucke A., et al. Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. BMC Infect Dis. 2008 ;8:21.
35.
Golub JE, Astemborski J., Ahmed M., et al. Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users. J Acquir Immune Defic Syndr. 2008;49:532-537.
36.
Velasco M., Castilla V., Sanz J., et al; COMESEM Cohort. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr. 2009;50:148-152.
37.
Shire NJ, Rouster SD, Stanford SD, et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:309-314.
38.
Ribes J., Clèries R., Rubió A., et al. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up. Int J Cancer . 2006;119:687-694.
39.
UK Collaborative Group on HIV Drug Resistance , UK Collaborative HIV Cohort Study, UK Register of HIV Seroconverters.Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom. AIDS. 2007;21:1035-1039.
40.
Tozzi V., Zaccarelli M., Narciso P., et al. Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort . J Infect Dis. 2004;189:1688-1695.
41.
Cozzi-Lepri A. , Phillips AN, Clotet B., et al; EuroSIDA Study Group.Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study. AIDS. 2008;22:2187-2198.
42.
Keiser PH, Nassar N.Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study. Int J STD AIDS. 2008;19:561-562.
43.
van der Leur MR, Burger DM, la Porte CJ, Koopmans PPA retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults. Ther Drug Monit. 2006;28:650-653.
44.
Park WB, Choe PG, Song KH, et al. Should HLA-B*5701 screening be performed in every ethnic group before starting abacavir? Clin Infect Dis. 2009;48:365-367.
45.
Kam KM, Wong KH, Li PCK, Lee SS, Leung WL, Kwok MYProposed CD4+ T-cell criteria for staging HIV-infected Chinese adults . Clin Immunol Immunopathol. 1998;89:11-22.
46.
Tong K., He ML, Lin CK, et al. The implication of a high allelic frequency of CYP2B6 G516T in ethnic Chinese. Clin Infect Dis. 2006;43:541-542.
47.
Cressey TR, Lallemant M.Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update. Infect Genet Evol. 2007 ;7:333-342.
48.
Farzadegan H., Hoover DR, Astemborski J., et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 1998;352:1510-1514.
49.
Kjaer J., Ledergerber B.HIV cohort collaborations: proposal for harmonization of data exchange . Antiviral Ther. 2004;9:631-633.
50.
Kamarulzaman A.Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Health. 2004;16:1-2.
